ATE226415T1 - Leberfunktionstest - Google Patents

Leberfunktionstest

Info

Publication number
ATE226415T1
ATE226415T1 AT98936568T AT98936568T ATE226415T1 AT E226415 T1 ATE226415 T1 AT E226415T1 AT 98936568 T AT98936568 T AT 98936568T AT 98936568 T AT98936568 T AT 98936568T AT E226415 T1 ATE226415 T1 AT E226415T1
Authority
AT
Austria
Prior art keywords
liver function
function test
patient
acid derivative
bile acid
Prior art date
Application number
AT98936568T
Other languages
English (en)
Inventor
Charles Oswald Mills
Original Assignee
Norgine Europe Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Europe Bv filed Critical Norgine Europe Bv
Application granted granted Critical
Publication of ATE226415T1 publication Critical patent/ATE226415T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043Fluorescein, used in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052Small organic molecules
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/583Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/728Bilirubin; including biliverdin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N
    • Y10T436/146666Bile pigment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98936568T 1997-08-12 1998-08-03 Leberfunktionstest ATE226415T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9716962.7A GB9716962D0 (en) 1997-08-12 1997-08-12 Liver function test
PCT/GB1998/002322 WO1999007325A1 (en) 1997-08-12 1998-08-03 Liver function test

Publications (1)

Publication Number Publication Date
ATE226415T1 true ATE226415T1 (de) 2002-11-15

Family

ID=10817313

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936568T ATE226415T1 (de) 1997-08-12 1998-08-03 Leberfunktionstest

Country Status (15)

Country Link
US (1) US6030841A (de)
EP (1) EP1003458B1 (de)
JP (1) JP3477616B2 (de)
KR (1) KR100444564B1 (de)
CN (2) CN1991367A (de)
AT (1) ATE226415T1 (de)
AU (1) AU732900B2 (de)
CA (1) CA2300097C (de)
DE (1) DE69808930T2 (de)
DK (1) DK1003458T3 (de)
ES (1) ES2183399T3 (de)
GB (1) GB9716962D0 (de)
HK (1) HK1024413A1 (de)
PT (1) PT1003458E (de)
WO (1) WO1999007325A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6640129B1 (en) * 1998-07-01 2003-10-28 Andreas Hoeft Determination of liver function using the rate at which plasma disappears
SE521014C2 (sv) 1999-02-04 2003-09-23 Prostalund Operations Ab Anordning för värmebehandling av prostata
SE521275C2 (sv) 1999-05-07 2003-10-14 Prostalund Operations Ab Anordning vid värmebehandling av kroppsvävnad
GB0017822D0 (en) * 2000-07-21 2000-09-06 Norgine Europe Bv Pharmaceutically active compound
US6868290B2 (en) 2001-11-05 2005-03-15 Prostalund Operations Ab Thermotherapy catheter and method of prostate thermotherapy with improved guide and heat confinement
EA011034B1 (ru) * 2001-11-26 2008-12-30 Кортекс Фармасеутикалс, Инк. Соединения карбонилбензоксазина для усиления глутаматергических синаптических ответов
CN100502763C (zh) * 2002-12-09 2009-06-24 味之素株式会社 生物体状态信息处理装置和其方法、以及生物体状态信息管理系统
GB0808777D0 (en) * 2008-05-15 2008-06-18 Norgine Bv Prognostic method
GB2467902A (en) 2009-02-12 2010-08-18 Norgine Bv Preparation of Cholyl-L-lysine from N-E-CBZ-cholyl-L-lysine
JP2010261871A (ja) * 2009-05-08 2010-11-18 Geno Membrane:Kk 標識化胆汁酸
CN102488525B (zh) * 2011-12-14 2014-04-16 吉林大学 一种去血氧波动干扰的肝储备功能检测装置
EP2885009A1 (de) * 2012-08-20 2015-06-24 Novassay SA Cholyl-l-lysyl-fluorescein-assay
CN104688234A (zh) * 2015-03-17 2015-06-10 吉林大学 一种icg色素浓度谱的无创、抗扰动检测方法
KR101882485B1 (ko) 2016-06-30 2018-07-27 강경찬 체내 간기능효소 및 지질 함유량 측정방법
CN106749473B (zh) * 2017-01-13 2018-08-17 常德云港生物科技有限公司 一种从鸭胆汁中提取鹅去氧胆酸和别胆酸的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264514A (en) * 1977-11-14 1981-04-28 Abbott Laboratories Method and reagents for measuring the level of conjugated bile acids
US4848349A (en) * 1987-04-29 1989-07-18 Sherman Igor A Substance and method for measuring hepatic blood flow
JPH0657216B2 (ja) * 1988-09-14 1994-08-03 住友電気工業株式会社 肝機能検査装置
GB9517043D0 (en) * 1995-08-19 1995-10-25 Univ Birmingham The use of bile acid derivatives

Also Published As

Publication number Publication date
HK1024413A1 (en) 2000-10-13
GB9716962D0 (en) 1997-10-15
KR100444564B1 (ko) 2004-08-16
WO1999007325A8 (en) 1999-03-25
AU8553098A (en) 1999-03-01
EP1003458B1 (de) 2002-10-23
ES2183399T3 (es) 2003-03-16
JP2001513584A (ja) 2001-09-04
WO1999007325A1 (en) 1999-02-18
AU732900B2 (en) 2001-05-03
CA2300097C (en) 2004-10-12
DK1003458T3 (da) 2002-11-18
DE69808930T2 (de) 2003-08-07
PT1003458E (pt) 2003-01-31
CA2300097A1 (en) 1999-02-18
CN1275060A (zh) 2000-11-29
CN1991367A (zh) 2007-07-04
KR20010022806A (ko) 2001-03-26
JP3477616B2 (ja) 2003-12-10
DE69808930D1 (de) 2002-11-28
EP1003458A2 (de) 2000-05-31
US6030841A (en) 2000-02-29

Similar Documents

Publication Publication Date Title
DE69808930T2 (de) Leberfunktionstest
DE60040335D1 (de) Derivatisierte nukleinsäuren und deren verwendung
ATE237277T1 (de) Zweite medizinische indikation einer partikelverabreichungsmethode
DE60041355D1 (de) Verfahren zur detektion von erkrankungen
MY133942A (en) Reagent test strip for analyte determination having hemolyzing agent
DE69836888D1 (de) Verfahren für Fluoreszenzerkennungstest
ATE394658T1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
BR9711869B1 (pt) mÉtodo e kit para coletar amostras de espÉcimes lÍquidas para teste analÍtico.
DK1047943T3 (da) Anordning til chromatografisk afprøvning af fremgangsmåde til påvisning af nærværelse af en analyt i en blodprøve
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
WO2004063704A3 (en) Vitamin d assay
ATE278803T1 (de) Verfahren zur überwachung der proteasomeinhibitorarzneimitteleffekte
WO2002093129A3 (en) Methods for analyzing interactions between proteins in live and intact cells
DK1410014T3 (da) Fremgangsmåde til identifikation af pröver fra et pattedyr samt kit til udövelse af fremgangsmåden
AU2003260457A1 (en) A method and kit for the quantitative and/or qualitative detection of components in a sample
WO2002012892A3 (en) Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke
DE69604920D1 (de) Verwendung einer phycobiliprotein-peptidkomplexverbindung als fluoreszenzlabel
WO2002035228A3 (de) Verfahren und testkit zum nachweis von analyten in einer probe
PT918991E (pt) Metodo de ensaio
EP2322910A3 (de) Ein Verfahren zur Analyse freier Zellen
AU2001225377A1 (en) Lipoprotein assay
WO1999007876A3 (de) Verfahren zur bestimmung von zellulärem protein
ATE221579T1 (de) Bestimmung von analyten unter verwendung zweier markierungen
DE59910326D1 (de) Verwendung derivatisierter Reagenzien in Chemilumineszenz- und Elektrochemilumineszenz-Nachweisverfahren
WO2004016802A3 (en) Methods and apparatus for preparing and assaying biological samples to determine protein concentration

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1003458

Country of ref document: EP

EEIH Change in the person of patent owner